Multiparametric analysis of magnetic resonance images for glioma grading and patient survival time prediction

Acta Radiologica

Volumn 52, Issue 9, 2011, Pages 1052-1060

  Garzón, Benjamín ^a   Emblem, Kyrre E ^b,c   Mouridsen, Kim ^d   Nedregaard, Baard ^b   Due Tønnessen, Paulina ^b   Nome, Terje ^b   Hald, John K ^b   Bjørnerud, Atle ^b   Håberg, Asta K ^a,e   Kvinnsland, Yngve ^f  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d AARHUS UNIVERSITY   (Denmark)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f NordicNeuroLab   (Norway)

Author keywords

Brain; MR imaging; Perfusion; Primary neoplasms

Indexed keywords

DIAGNOSTIC ACCURACY; DYNAMIC SUSCEPTIBILITY CONTRAST; FEATURE COMBINATION; FIRST MOMENTS; IMAGE FEATURES; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGES; MR IMAGING; MULTIPARAMETRIC ANALYSIS; ORIGINAL IMAGES; PERFUSION; PREDICTIVE VALUES; PRESENCE/ABSENCE; PRIMARY NEOPLASMS; REGION OF INTEREST; SELECTION PROCEDURES; STATISTICAL FEATURES; SURVIVAL PREDICTION; SURVIVAL TIME; TUMOR GRADES; TUMOR VOLUMES;

BRAIN; FEATURE EXTRACTION; FORECASTING; MAGNETIC SUSCEPTIBILITY; MEDICAL IMAGING; TUMORS;

MAGNETIC RESONANCE IMAGING;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; FEMALE; GLIOMA; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING;

EID: 83155165157     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.100510     Document Type: Article

References (34)

1. Schwartzbaum JA, Fisher JL, Aldape KD, et al. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006;2:494-503 (Pubitemid 44275725)
2. Louis DN, Ohgaki H, Wiestler OD, et al. Astrocytic tumours and Oligodendroglial tumours. WHO classification of tumours of the central nervous system. 4th edn. Astrocytic tumours and Oligodendroglial tumours WHO classification of tumours of the central nervous system 4th edition. Lyon: IARC, 2007:8-11
3. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 2003;24:1989-98 (Pubitemid 37444849)
4. Law M, Young RJ, Babb J, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast enhanced perfusion MR imaging. Radiology 2008;247:490-8
5. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am J Roentgenol 2002;179:783-9 (Pubitemid 34919600)
6. Sugahara T, Korogi Y, Shigematsu Y, et al. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. Top Magn Reson Imaging 1999;10:10
7. Jenkinson MD, Du Plessis DG, Walker C, et al. Advanced MRI in the management of adult gliomas. Br J Neurosurg 2007;21:550-61 (Pubitemid 350249197)
8. Simon M, Schramm J. Surgical management of intracranial gliomas. Recent Results Cancer Res 2009;171:105-24
9. Graif M, Bydder GM, Steiner RE, et al. Contrast-enhanced MR imaging of malignant brain tumors. Am J Neuroradiol 1985;6:855-62 (Pubitemid 16226994)
10. Ostergaard L. Cerebral perfusion imaging by bolus tracking. Top Magn Reson Imaging 2004;15:3-9 (Pubitemid 38437541)
11. Cha S. Perfusion MR imaging: basic principles and clinical applications. Magn Reson Imaging Clin N Am 2003;11:403-13 (Pubitemid 37484243)
12. Law M, Young R, Babb J, et al. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. Am J Neuroradiol 2007;28:761-6 (Pubitemid 46608621)
13. Emblem KE, Nedregaard B, Nome T, et al. Glioma grading using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008;247:808-17
14. Mills SJ, Soh C, O'Connor JP, et al. Tumour enhancing fraction (EnF) in glioma: relationship to tumour grade. Eur Radiol 2009;19:1489-98
15. White M, Zhang Y, Kirby P, et al. Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? Am J Neuroradiol 2005;26:784-90 (Pubitemid 43079768)
16. Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging-prediction of patient clinical response. Radiology 2006;238:658-67 (Pubitemid 43134379)
17. Patankar TF, Haroon HA, Mills SJ, et al. Is volume transfer coefficient (K (trans)) related to histologic grade in human gliomas? Am J Neuroradiol 2005;26:2455-65
18. Mills SJ, Patankar TA, Haroon HA, et al. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? Am J Neuroradiol 2006;27:853-8 (Pubitemid 44897736)
19. Wolf RL, Wang J, Wang S, et al. Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J Magn Reson Imaging 2005;22:475-82 (Pubitemid 41416406)
20. Hamstra DA, Chenevert TL, Moffat BA, et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci USA 2005;102:16759-64 (Pubitemid 41688850)
21. Pope WB, Kim HJ, Huo J, et al. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Radiology 2009;252:182-9
22. Zeng Q, Liu H, Zhang K, et al. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy. Magn Reson Imaging 2011;29:25-31
23. Erb G, Elbayed K, Piotto M, et al. Toward improved grading of malignancy in oligodendrogliomas using metabolomics. Magn Reson Med 2008;59:959-65 (Pubitemid 351590507)
24. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:208-19
25. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. Am J Neuroradiol 2006;27:859-67 (Pubitemid 44897737)
26. Friston KJ, Holmes AP, Worsley KJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210 (Pubitemid 124008664)
27. Schmainda KM, Rand SD, Joseph AM, et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. Am J Neuroradiol 2004;25:1524-32 (Pubitemid 44383603)
28. Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology 2003;229:3-8 (Pubitemid 37152094)
29. Shao J. Linear Model Selection by Cross-Validation. Journal of the American Statistical Association 1993;88:486-94
30. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd edn. New York, NY: Wiley Interscience, 2000:31-3
31. Cox D, Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1984:70-1
32. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974;19:716-23
33. R-Development-Core-Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2008
34. Vajkoczy P, Menger MD. Vascular microenvironment in gliomas. J Neurooncol 2000;50:99-108 (Pubitemid 32166294)